Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Pharmaceutics|March 2, 2016
Venetoclax (ABT-199) Might Act as a Perpetrator in Pharmacokinetic Drug-Drug InteractionsJohanna Weiss, Thomas Gajek, Bruno Christian Köhler, et al.
The Journal of Pharmacy and Pharmacology|August 11, 2015
Obatoclax as a perpetrator in drug-drug interactions and its efficacy in multidrug resistance cell linesDirk Theile, David Allendorf, Bruno Christian Köhler, et al.
Communications Medicine|October 1, 2025
Association of leukocyte composition ratios from blood methylation with cancer mortality outcomesZiwen Fan, Dominic Edelmann, Zitong Zhao, et al.
NPJ Precision Oncology|September 5, 2024
Developing survival prediction models in colorectal cancer using epigenome-wide DNA methylation data from whole bloodZiwen Fan, Dominic Edelmann, Tanwei Yuan, et al.
Future Oncology (London, England)|May 27, 2026
Sacituzumab govitecan in colorectal cancer: clinical evidence and future directionsLuisa Nader, Paula Hoffmeister-Wittmann, Georg Martin Haag, et al.
Oncotarget|September 24, 2017
Liver cancers with stem/progenitor-cell features - a rare chemotherapy-sensitive malignancyBruno Christian Köhler, Nina Waldburger, Kai Schlamp, et al.
Oncotarget|May 19, 2018
An undifferentiated carcinoma at Klatskin-position with long-term complete remission after chemotherapyBruno Christian Köhler, Benjamin Goeppert, Nina Waldburger, et al.
International Journal of Oncology|November 27, 2010
Down-regulation of CYLD as a trigger for NF-κB activation and a mechanism of apoptotic resistance in hepatocellular carcinoma cellsToni Urbanik, Bruno Christian Köhler, Regina Johanna Boger, et al.
International Journal of Molecular Sciences|February 13, 2020
Knockdown of Atg7 Induces Nuclear-LC3 Dependent Apoptosis and Augments Chemotherapy in Colorectal Cancer CellsAnna-Lena Scherr, Adam Jassowicz, Anna Pató, et al.
Pageof 2